$8.15
0.12%
Nasdaq, Sep 21, 04:18 pm EDT. Closed.
ISIN
US03675P1021
Symbol
AVR

Anteris Technologies Stock price

$8.15
-0.83 9.24% 1M
+2.68 48.99% 6M
+3.16 63.33% YTD
+3.25 66.33% 1Y
+2.15 35.83% 3Y
+2.15 35.83% 5Y
+2.15 35.83% 10Y
+2.15 35.83% 20Y
Nasdaq, Closing price Mon, Sep 21 2026
-0.01 0.12%
ISIN
US03675P1021
Symbol
AVR

Is Anteris Technologies a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
$794.3m
Enterprise Value
$537.4m
Net debt
positive
Cash
$257.4m
Shares outstanding
97.4m
Valuation (TTM | estimate)
P/E
negative
P/S
354.6 | 84.9
EV/Sales
239.9 | 57.5
EV/FCF
negative
P/B
3.2
Financial Health
Equity Ratio
-0.4%
Return on Equity
101,230.1%
ROCE
-41.8%
ROIC
-3,139.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.2m | $9.4m
EBITDA
$-104.5m
EBIT
$-106.2m
Net Income
$-103.6m
Free Cash Flow
$-88.3m
Growth (TTM | estimate)
Revenue
-9.7% | 390.5%
EBITDA
-23.9%
EBIT
-22.6%
Net Income
-23.7%
Free Cash Flow
16.0%
Margin
Gross
75.0%
EBITDA
-4,660.8%
EBIT
-4,738.4%
Net
-4,619.3%
Free Cash Flow
-3,936.4%
More
EPS
$-1.1
FCF per Share
$-0.9
Short interest
10.2%
Employees
174
Rev per Employee
$10.0k

Anteris Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Anteris Technologies forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Anteris Technologies forecast:

Buy
88%
Hold
13%

Financial data from Anteris Technologies

Jun '26
+/-
%
2.24 2.24
10% 10%
100%
- Direct Costs 0.56 0.56
45% 45%
25%
1.68 1.68
14% 14%
75%
- Selling and Administrative Expenses 31 31
17% 17%
1,374%
- Research and Development Expense 77 77
28% 28%
3,444%
-105 -105
24% 24%
-4,665%
- Depreciation and Amortization 1.74 1.74
25% 25%
78%
EBIT (Operating Income) EBIT -106 -106
23% 23%
-4,743%
Net Profit -104 -104
24% 24%
-4,623%

In millions USD.

Don't miss a Thing! We will send you all news about Anteris Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Anteris Technologies Stock News

Neutral
GlobeNewsWire
about one month ago
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corpor...

Company Profile

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 174 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The firm's ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

Head office United States
CEO Mr. Paterson
Employees 174
Website anteristech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today